Asieris Pharmaceuticals is a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases. Today the company announced the completion of their Series D Round of financing. This round of funding was led by Qiming Venture Partners, and joined by YF Capital, CICC Transfer […]
Chinese Biopharma Firm Asieris Completes RMB700M Round comes from China Money Network: Primary Data for China’s Primary Markets! All Rights Reserved.